Free Newsletter
Bacteria prompts nasal spray recall
A contaminated batch of raw material has led to the recall of 120,000 bottles Vicks Sinex nasal spray. The recall is precautionary, says maker Procter & Gamble, and is based on the detection of B. cepacia bacteria in a product sample from a manufacturing plant in Germany.
The bacteria resists antibiotics, according to a report in AboutLawsuits.com. In 2004, the same bacteria contaminated Propharma's Major Twice-A-Day nasal spray, also leading to a recall.
P&G quality control inspectors found the problem during a routine product check and set the consumer safety wheels in motion. Analysis to date shows the contamination limited to the one batch. The company says it detected the contamination in product from a lot sold in the United States. It is testing the U.K. and German lots produced from the same batch of raw material mixture.
- here's the P&G announcement
- read the AboutLawsuits article
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities


SHARE
WITH: